Brief: Sesen Bio Receives Nasdaq Delisting Notice
30/01/2023 14:37
Jan 30 (Reuters) - Sesen Bio Inc SESN.O :
* SESEN BIO RECEIVES NASDAQ DELISTING NOTICE
Source text for Eikon: ID:nBw5dKvQQa
Further company coverage: SESN.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Carisma Therapeutics
See all newsBrief: Carisma Therapeutics & Modernatx Amend Collaboration & And License Agreement - SEC Filing
Carisma Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Carisma Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Carisma Therapeutics And Orthocellix Enter Into Definitive Merger Agreement
Carisma Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary